Commentary

Will They Still Give Strong to Lance Armstrong's Cancer Charity?


 

And that’s just the sports money.

It seems likely that charitable enthusiasm may wane as well, as the reality sets in that Lance Armstrong, the invincible hero, was always just a man, and one who many must conclude compromised his ethics (and ironically, the sanctity of his cancer-free body) to win.

Dr. Freed is a psychologist in Santa Barbara, Calif., and a medical journalist.

Pages

Recommended Reading

BG-12 Cuts Relapse Rate, Lesions in Multiple Sclerosis
MDedge Neurology
CombiRx for MS Not Better Than Monotherapy
MDedge Neurology
Interferon-Beta Fails to Slow the Progression of Disability in MS
MDedge Neurology
FDA Reports Seizure Risk With MS Drug
MDedge Neurology
Laquinimod May Be Effective for the Long-Term Management of Multiple Sclerosis
MDedge Neurology
New and Noteworthy Information—August
MDedge Neurology
Long-Term Data Indicate Interferon Beta-1b Reduces the Risk of Death for Patients With MS
MDedge Neurology
Interferon Beta May Not Reduce Disability Progression for Patients With MS
MDedge Neurology
Should Patients Continue Natalizumab Treatment After a Positive JCV Test?
MDedge Neurology
Cognitive Rehabilitation Improves Quality of Life in Patients With MS
MDedge Neurology